Kelly, Kathleen
- Division of Basic Sciences - Nci (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #3,126
- Sustained Excellence
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2007 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$2.2M
Full award amounts, FY2023
Award Records
3
Records listing this PI
Award-Linked Rank
#3,126
By linked amount among FY2023 PIs
Earliest Year Loaded
2007
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Kelly, Kathleen as a PI. Multi-PI records show the full award amount for context.
- 1ZIABC011782-07ZIAContact PIMechanisms of pathogenesis in patient derived organoid models of prostate cancer$1.3Maward amount
- 1ZIABC012111-02ZIAContact PIBiology of AR+ prostate cancer metastases and the role of the microenvironment$556.7Kaward amount
- 1ZIABC011919-05ZIAContact PIIdentifying genetic vulnerabilities in neuroendocrine prostate cancer$334Kaward amount
Award organization
Organizations that administered FY2023 awards listing Kelly, Kathleen as a PI.
FY2023 award administered by Division of Basic Sciences - Nci ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2007First NIH AwardDivision of Basic Sciences - Nci
- 2007$500K Cumulative Funding
- 2007$1M Cumulative Funding
- 2007Entered Top 50% NationallyRanked #5421
- 2008$2M Cumulative Funding
- 2009Entered Top 25% NationallyRanked #4889
- 2011$5M Cumulative Funding
- 2014$10M Cumulative Funding
- 2018Entered Top 10% NationallyRanked #1970
- 2023$25M Cumulative Funding